Search filters

List of works by Jason Konner

A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

scientific article published on 08 January 2016

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer

scientific article published on 10 December 2024

A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors

article

A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer

scientific article

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.

scientific article

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

article

A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer

scientific article

Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study

scientific article published on 9 January 2009

Alternative Careers for Physicians

scientific article published in The Journal of the American Medical Association

Authors' reply to Drs. Khattak and Martin

Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status

scientific article published on 18 May 2019

Breaking down the evidence for bevacizumab in ovarian cancer

scientific article published on 19 January 2015

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery

scientific article published on 01 January 2020

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

scientific article

Consolidation strategies in ovarian cancer: observations for future clinical trials

scientific article published on January 2010

Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer

scientific article published on 09 June 2020

Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy

scientific article published on 09 February 2007

Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study

scientific article published on 20 September 2010

Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies

scientific article published on June 2013

Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience

scientific article

Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma

article

Intraperitoneal chemotherapy in older women with epithelial ovarian cancer

article

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

scientific article

New drugs for ovarian cancer

scientific article published on December 2011

Ovarian clear cell carcinoma, outcomes by stage: the MSK experience

scientific article

Pancreatic cancer: epidemiology, genetics, and approaches to screening.

scientific article

Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.

scientific article

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer

scientific article published on 7 October 2011

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

article

Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma

scientific article

Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer

scientific article published on 7 November 2011

Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer

scientific article

Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.

scientific article published on April 2008

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer

article

Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up

scientific article

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer

article

Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.

scientific article

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.

scientific article

Paulina is supported by:

About Paulina

Help